Table 1 Sample description
From: Vulnerability to stress, anxiety and depressive symptoms and metabolic control in Type 2 diabetes
Total sample | Patients by glycemic control level | |||
|---|---|---|---|---|
N = 273 | N = 107 | N = 166 | ||
HbA1c < 8 | HbA1c ≥ 8 | P | ||
Age (years) | 57.68 ± 5.81 | 59.15 ± 4.69 | 56.74 ± 6.26 | 0.001 |
Gender (male) | 139 (50.9) | 54 (50.5) | 85 (51.2) | 1.000 |
Education level (years) | 7 ± 4.20 | 7.23 ± 4.29 | 6.85 ± 4.14 | 0.469 |
BMI (kg/m2) | 30.08 ± 4.42 | 30.02 ± 4.37 | 30.12 ± 4.50 | 0.858 |
Diabetes duration | 13.95 ± 7.08 | 13.44 ± 7.91 | 14.27 ± 6.49 | 0.346 |
≥ 1 chronic complications | 132 (48.4) | 46 (43.0) | 86 (51.8) | 0.173 |
Insulin users | 159 (58.2) | 46 (43.0) | 113 (68.1) | <0.001 |
Antidepressant users | 31 (11.4) | 12 (11.2) | 19 (11.4) | 1.000 |
HbA1c | 8.68 ± 1.71 | |||
HADS depression | 4.45 ± 3.59 | 3.93 ± 3.11 | 4.7 ± 3.84 | 0.047 |
HADS anxiety | 7.24 ± 3.84 | 7.31 ± 3.94 | 7.19 ± 3.78 | 0.803 |
23QVS | 42.70 ± 10.59 | 42.61 ± 9.20 | 42.76 ± 11.43 | 0.910 |